Sens-AVK-Study
Recruiting
- Conditions
- Peripheral arterial occlusive disease, intermittent claudication stages IIa-IIb according to Fontaine/ 1-3
- Registration Number
- DRKS00033683
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Ability to give informed consent; clinical complaint stage pAVK IIa-IIb acc. Fontaine/1-3 Rutherford; signed informed consent form; willingness for follow-up examinations; endovascular procedure if indicated
Exclusion Criteria
Refusal of data collection; discontinuation of the study; patient is unable to give informed consent; open surgical procedure, if indicated; life expectancy < 24 months; treatment-relevant cancer, advanced dementia; stroke with persistent hemiparesis; COPD grade Gold C or D; Parkinson's disease Hoehn and Yahr stages IV - V; severe degenerative joint disease with planned surgery;
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The data is intended to provide predictive values for determining the best individual therapy method, for determining the optimized use of the various therapy methods and walking distance, and for the quality of the results.
- Secondary Outcome Measures
Name Time Method